Premium
X4 Pharmaceuticals Inc (XFOR)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
X4 Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases of the immune system. It offers XOLREMDI, an orally small-molecule selective antagonist of chemokine receptor CXCR4, which is in... X4 Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases of the immune system. It offers XOLREMDI, an orally small-molecule selective antagonist of chemokine receptor CXCR4, which is in phase 3 clinical trial for the treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome. It has a license agreement with Abbisko Therapeutics Co Ltd. to manufacture and distribute XOLREMDI in mainland China, Taiwan, Hong Kong and Macau; Norgine to develop, manufacture, and commercialize mavorixafor in Europe, Australia, and New Zealand; and Genzyme Corporation for CXCR4 receptor to develop and commercialize products containing licensed compounds for all therapeutic, prophylactic and diagnostic uses. The company is headquartered in Boston, Massachusetts. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.22 | -5.33980582524 | 4.12 | 4.36 | 3.83 | 499964 | 4.13344995 | CS |
| 4 | -0.45 | -10.3448275862 | 4.35 | 4.6 | 3.56 | 368095 | 4.0857986 | CS |
| 12 | 0.02 | 0.515463917526 | 3.88 | 4.66 | 3.53 | 383631 | 4.1208882 | CS |
| 26 | -0.04 | -1.0152284264 | 3.94 | 4.83 | 2.83 | 467622 | 3.90931519 | CS |
| 52 | -0.19 | -4.64547677262 | 4.09 | 4.83 | 1.35 | 1490454 | 2.99098993 | CS |
| 156 | 1.7 | 77.2727272727 | 2.2 | 6.63 | 0.1701 | 2103759 | 1.40363829 | CS |
| 260 | -5.03 | -56.326987682 | 8.93 | 9.7 | 0.1701 | 1624717 | 1.49193514 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
